Michael Rice - Rockwell Medical Insider

Rockwell Medical -- USA Stock  

USD 5.66  0.17  3.10%

Co-Founder, LifeSci Advisors, LLC

We currently do not have informatin regarding Michael Rice. This executive tanure with Rockwell Medical is not currenlty determined.
        
248-960-9009  http://www.rockwellmed.com

Michael Rice Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (22.83) % which means that it has lost $22.83 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (60.37) % meaning that it created substantial loss on money invested by shareholders.

Entity Summary

Rockwell Medical, Inc. operates as an integrated biopharmaceutical company targeting end-stage renal and chronic kidney diseases in the United States and internationally. Rockwell Medical, Inc. was founded in 1995 and is based in Wixom, Michigan. Rockwell Medical operates under Drug Manufacturers - Major classification in USA and traded on NASDAQ General Markets. It employs 300 people.Rockwell Medical (RMTI) is traded on NASDAQ General Markets in USA. It is located in MICHIGAN, U.S.A and employs 300 people. Rockwell Medical is listed under Medical Equipment category by Fama And French industry classification.

Rockwell Medical Leadership Team

John Cooper, Director
David Domzalski, Director
Thomas Klema, President, MBA
Ajay Gupta, Executive
Ronald Boyd, Director
Lisa Colleran, Director
Kenneth Holt, Director
Benjamin Wolin, Chairman
Raymond Pratt, Executive, Ph.D
Robin Smith, Director, MBA
Patrick Bagley, Director
Robert Chioini, Chairman
Michael Rice, Founder

Stock Performance Indicators

Current Sentiment - RMTI

Rockwell Medical Investor Sentiment
Most of Macroaxis users are at this time bullish on Rockwell Medical. What is your perspective on investing in Rockwell Medical? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Trending Equities

Currently Active Assets on Macroaxis
F   
 NYQ 
Purchased over 200 shares of
2 days ago
Traded for 10.96
MSFT   
 NMS 
Purchased over 30 shares of
2 days ago
Traded for 96.11
GM   
 NYQ 
Purchased over 70 shares of
2 days ago
Traded for 37.77
DD   
 NYQ 
Purchased over 100 shares of
2 days ago
Traded for 30.6
CRM   
 NYQ 
Purchased over 20 shares of
2 days ago
Traded for 124.06
RKDA   
 NCM 
Purchased over 100 shares of
2 days ago
Traded for 23.82
Additionally take a look at Your Equity Center. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.